Literature DB >> 4429180

Some observations on the pharmacology of clofazimine (B663).

D K Banerjee, G A Ellard, P T Gammon, M F Waters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4429180     DOI： 10.4269/ajtmh.1974.23.1110

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  18 in total

1.  Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.

Authors:  Sandeep Tyagi; Nicole C Ammerman; Si-Yang Li; John Adamson; Paul J Converse; Rosemary V Swanson; Deepak V Almeida; Jacques H Grosset
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

2.  Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.

Authors:  Kathy Williams; Austin Minkowski; Opokua Amoabeng; Charles A Peloquin; Dinesh Taylor; Koen Andries; Robert S Wallis; Khisimuzi E Mdluli; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

3.  Elasticity in Macrophage-Synthesized Biocrystals.

Authors:  Elizabeth M Horstman; Rahul K Keswani; Benjamin A Frey; Phillip M Rzeczycki; Vernon LaLone; Jeffery A Bertke; Paul J A Kenis; Gus R Rosania
Journal:  Angew Chem Int Ed Engl       Date:  2017-01-12       Impact factor: 15.336

4.  Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.

Authors:  Rosemary V Swanson; Nicole C Ammerman; Bongani Ngcobo; John Adamson; Chivonne Moodley; Afton Dorasamy; Sashen Moodley; Zinhle Mgaga; Linda A Bester; Sanil D Singh; Deepak V Almeida; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

5.  Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis.

Authors:  Rosemary V Swanson; John Adamson; Chivonne Moodley; Bongani Ngcobo; Nicole C Ammerman; Afton Dorasamy; Sashen Moodley; Zinhle Mgaga; Asa Tapley; Linda A Bester; Sanil Singh; Jacques H Grosset; Deepak V Almeida
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

6.  Chemical Analysis of Drug Biocrystals: A Role for Counterion Transport Pathways in Intracellular Drug Disposition.

Authors:  Rahul K Keswani; Jason Baik; Larisa Yeomans; Chuck Hitzman; Allison M Johnson; Ashtamurthy S Pawate; Paul J A Kenis; Nair Rodriguez-Hornedo; Kathleen A Stringer; Gus R Rosania
Journal:  Mol Pharm       Date:  2015-06-05       Impact factor: 4.939

7.  Molecular imaging of intracellular drug-membrane aggregate formation.

Authors:  Jason Baik; Gus R Rosania
Journal:  Mol Pharm       Date:  2011-08-12       Impact factor: 4.939

8.  Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas.

Authors:  Scott M Irwin; Veronica Gruppo; Elizabeth Brooks; Janet Gilliland; Michael Scherman; Matthew J Reichlen; Rachel Leistikow; Igor Kramnik; Eric L Nuermberger; Martin I Voskuil; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

Review 9.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

10.  The action of Clofazimine on the level of lysosomal enzymes of cultured macrophages.

Authors:  J Sarracent; C M Finlay
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.